About Zenflow
Zenflow is a company based in Palo Alto (United States) founded in 2014 by Shreya Mehta. Zenflow has raised $48 million across 6 funding rounds from investors including NIH, Square 1 Bank and Cook Medical. The company has 25 employees as of December 31, 2020. Zenflow offers products and services including Zenflow Procedure. Zenflow operates in a competitive market with competitors including Neotract, Urotronic, Butterfly Medical, Rivermark and ProVerum Medical, among others.
- Headquarter Palo Alto, United States
- Employees 25 as on 31 Dec, 2020
- Founders Shreya Mehta
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zenflow, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48 M (USD)
in 6 rounds
-
Latest Funding Round
$24 M (USD), Series C
Nov 01, 2024
-
Investors
NIH
& 12 more
-
Employee Count
25
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zenflow
Zenflow offers a comprehensive portfolio of products and services, including Zenflow Procedure.
Gentle, effective method for enlarged prostate relief with fast recovery and lasting benefits.
People of Zenflow
Unlock access to complete
Funding Insights of Zenflow
Zenflow has successfully raised a total of $48M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $24 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Zenflow
Zenflow has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, Square 1 Bank and Cook Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-term private equity investments in transformational opportunities are pursued.
|
Locked | Locked | Locked | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Locked | Locked | Locked | |
|
MedTech Venture Partners is focused on medical technology investments.
|
Locked | Locked | Locked |
Investor details for Zenflow
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zenflow
Investment portfolio details for Zenflow
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zenflow
Detailed financials for Zenflow
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zenflow Comparisons
Peer comparison for Zenflow
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zenflow
Zenflow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neotract, Urotronic, Butterfly Medical, Rivermark and ProVerum Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Minimally invasive devices in urology
|
|
| Locked | Locked | Locked |
Urethral stricture treatment devices are developed by Urotronic.
|
|
| Locked | Locked | Locked |
Developer of an implantable device for the treatment of benign prostatic hyperplasia (BPH)
|
|
| Locked | Locked | Locked |
Medical device for benign prostatic hyperplasia treatment is developed.
|
|
| Locked | Locked | Locked |
Developer of a minimally-invasive medical device for benign prostatic hyperplasia
|
Detailed competitors of Zenflow
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zenflow
Complete news archive for Zenflow
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zenflow
Zenflow was founded in 2014.
Zenflow is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Shreya Mehta is the current CEO of Zenflow. They have also founded this company.
Zenflow is a funded company, having raised a total of $48M across 6 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Zenflow is 25.
Zenflow was founded in 2014 in Palo Alto, United States, within the medical device sector focused on urology. A device called the Spring Implant is being developed to address urinary obstruction associated with benign prostatic hyperplasia. The procedure is designed for the prostatic urethra and completed in a 10-minute outpatient setting. Core operations involve device innovation for minimally invasive treatments in this field.
Zenflow offers Zenflow Procedure.
Zenflow has 13 investors. Key investors include NIH, Square 1 Bank, Cook Medical, Invus, and F-Prime Capital.